Ignite Creation Date:
2025-12-24 @ 7:35 PM
Ignite Modification Date:
2025-12-25 @ 5:16 PM
Study NCT ID:
NCT00276003
Status:
COMPLETED
Last Update Posted:
2010-01-07
First Post:
2006-01-11
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
Sponsor:
University of New Mexico
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-08
Start Date Type:
None
Primary Completion Date:
2005-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-08
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-11
First Submit QC Date:
None
Study First Post Date:
2006-01-12
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2010-01-06
Last Update Post Date:
2010-01-07
Last Update Post Date Type:
ESTIMATED